Dalteparin Injection and Skullcap: Interaction Details
- Dalteparin Injection
- Fragmin
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Dalteparin Injection and Skullcap interaction:
Dalteparin Injection
- Fragmin
Skullcap
We don't have a drug information page for Skullcap yet. Have a question about Skullcap? Ask a pharmacist, free →
What Happens When You Take Dalteparin Injection With Skullcap
What can happen when they are taken together (rated Moderate)
Increased risk of bleeding
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
In rat studies, the flavonoid constituents of skullcap showed activity against aggregation, and certain of these components were found to be as potent as aspirin or more so.1 On theoretical grounds, then, using skullcap together with low molecular weight heparins could lead to excessive bleeding. Caution is recommended.
The Dalteparin Injection and Skullcap Interaction, Explained
Dalteparin (Fragmin) is a shot that helps prevent dangerous clots. Skullcap is an herbal supplement. Some lab studies in rats suggest skullcap may make (tiny blood cells that help form clots) less sticky, a bit like aspirin does. Taken together, the two could add up and raise your chance of bleeding.
This concern is theoretical, based mostly on animal research, not on problems seen in people. Keep taking your medicine as prescribed, and let your pharmacist or doctor know you use skullcap. Your care team can watch for bleeding and help keep you safe.
Mechanism: effect. Skullcap (Scutellaria) flavonoids inhibited aggregation in rats (some constituents equal to or greater than aspirin) and may impair fibrinogen to fibrin conversion. Combined with dalteparin's anti-Xa activity, bleeding risk may increase. No interaction is expected.
- Direction: Increased bleeding risk; magnitude unquantified.
- Onset: Delayed.
- Evidence: Theoretical (animal data only; no human reports documented).
- Severity: Moderate.
- Management: Use caution. Confirm supplement use and monitor for signs and symptoms of bleeding (bruising, mucosal or bleeding, hematuria). Counsel the patient to report bleeding promptly.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Dalteparin Injection and Skullcap Interact
The likely mechanism
of aggregation and the conversion of fibrinogen to fibrin by skullcap
How to Manage the Dalteparin Injection and Skullcap Interaction
Your care team can manage this safely by keeping a closer eye on you.
- What your team may do: Use extra caution and monitor you more closely for signs of bleeding.
- What you can do: Keep using dalteparin exactly as prescribed. Tell your pharmacist or doctor that you take skullcap, and ask before starting or stopping any herbal product.
- Watch for: Unusual bruising, bleeding gums, nosebleeds that won't stop, pink or dark urine, or black stools. Report these to your care team right away.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Dalteparin Injection or Skullcap need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there anything you'd monitor while I'm on both?
Literature Reports
1 report from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Studies on Scutellariae radix
In rats, flavonoids obtained from Scutellariae radix (skullcap) suppressed aggregation triggered by several different agents. Collagen-induced platelet aggregation was reduced by 21.6% with aspirin 1 millimole (mmol), while equal concentrations of the flavonoids baicalein, baicalin, wogonin, wogonin-7-O-D-glucuronide, oroxylin A, skullcapflavone II, and chrysin reduced platelet aggregation by 23.3%, 12.4%, 24.7%, 8.9%, 43.8%, 32.5%, and 23.4%, respectively.
Aspirin 1 mmol reduced platelet aggregation induced by arachidonic acid by 30.4%, while baicalein, baicalin, and wogonin at 1 mmol each reduced it by 47.7%, 31.3%, and 45.5%, respectively. Baicalein and baicalin also inhibited the conversion of fibrinogen to fibrin induced by thrombin.1
Dalteparin Injection and Skullcap: Common Questions
How serious is the Dalteparin Injection and Skullcap interaction?
It is rated moderate. Can be significant — usually manageable with monitoring.
How is the Dalteparin Injection and Skullcap interaction managed?
Your care team can manage this safely by keeping a closer eye on you. What your team may do: Use extra caution and monitor you more closely for signs of bleeding. What you can do: Keep using dalteparin exactly as prescribed. Tell your pharmacist or doctor that you take skullcap, and ask before starting or stopping any herbal product. Watch for: Unusual bruising, bleeding gums, nosebleeds that won'… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "delayed". Effects tend to build up gradually over days to weeks.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Dalteparin Injection and Skullcap Interaction
Ask in your own words about taking Dalteparin Injection and Skullcap together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Kubo M, Matsuda H, Tani T, et al: Studies on Scutellariae radix. XII. Anti-thrombic actions of various flavonoids from Scutellariae radix. Chem Pharm Bull 1985; 33:2411-2415. PubMed
Other Serious Interactions of Dalteparin Injection and Skullcap
Also serious with Dalteparin Injection
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring.
- Moderate Can be significant — usually manageable with monitoring. This interaction.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks. This interaction.
- UnspecifiedThe timing of this interaction is not well characterized.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.